Anticancer agent 269
Product Specifications
Target
Apoptosis, Reactive Oxygen Species, Caspase, ROS
Related Pathways
Immunology/Inflammation, Proteases/Proteasome, NF-κB, Metabolism, Apoptosis
Bioactivity
Anticanceragent 269 (Compound 11c) is an orally active caspase-3 activator that exhibits significant anticancer activity by inducing apoptosis through the activation of caspase-3 and promoting ROS generation. It is a valuable compound for research within the cancer field.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
